liberty trial: erenumab in episodic migraine patients with prior preventive treatment failures
Published 4 years ago • 83 plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
1:56
early 2: erenumab in the prevention of high-frequency episodic & chronic migraine in the real world
-
3:30
peter goadsby, ean 2018 – erenumab in difficult-to-treat episodic migraine: liberty study
-
19:11
benefit of migraine prevention with erenumab
-
2:52
fremanezumab in patients with chronic or episodic migraine
-
2:30
her-mes study: erenumab versus topiramate in episodic migraine
-
7:37
erenumab in migraine with or without aura: cardiovascular safety
-
2:09
challenges in migraine management
-
3:40
erenumab in migraine therapy: clinical data
-
6:07
practical implications of the strive and arise trials
-
5:24
dr stephen silberstein shares 5-year efficacy, safety data on erenumab
-
1:39
dr stephen silberstein compares the effects of erenumab on chronic, episodic migraine
-
2:44
promise-1: eptinezumab in episodic migraine
-
5:25
erenumab (aimovig) current safety profile: a detailed look at preventing migraines
-
9:29
conquer: galcanezumab in treatment-resistant migraine
-
6:07
practical implications of the strive and arise trials
-
4:30
aimovig® (erenumab-aooe) mechanism of action for the preventive treatment of migraine
-
2:25
breakthrough for migraine sufferers
-
11:59
revolutionize migraine treatment with erenumab injection
-
1:26
peter j. goadsby, md, phd, dsc: migraine prevention post-approval of erenumab